University of Cambridge > > Cancer Research UK Cambridge Institute (CRUK CI) Seminars in Cancer > Cellular Conversations that Control Cancer

Cellular Conversations that Control Cancer

Add to your list(s) Download to your calendar using vCal

  • UserThea D Tlsty, University of California San Francisco (UCSF) Helen Diller Comprehensive Cancer Center and Department of Pathology, 513 Parnassus Avenue, San Francisco, CA 94143-0511 World_link
  • ClockFriday 26 April 2019, 13:00-14:00
  • HouseCRUK CI Lecture Theatre.

If you have a question about this talk, please contact Kate Davenport.

***Please note this seminar is on a Friday***

A wealth of evidence has demonstrated that the microenvironment in which a tumorigenic cell evolves is as critical to its evolution as the genetic mutations it accrues. We found that carcinoma-associated fibroblasts (CAFs), and the distinct ECM they deposit, can cause increased dissemination and metastasis, while healthy fibroblasts constrain these traits. A defining molecular characteristic of CAFs is their repression of CD36 and the reprogramming of adjacent cells in the stromal microenvironment that ensues. Using both in vitro and in vivo assays, we demonstrated that CD36 repression is necessary and sufficient to recapitulate the pro-tumorigenic phenotypes observed in desmoplasia. Consistent with a functional role for this coordinated, multi-cellular program in tumorigenesis, we observed that clinical outcomes were strongly associated with low CD36 expression. Modulating CD36 may be a valuable tool in prevention and intervention of carcinogenesis.

This talk is part of the Cancer Research UK Cambridge Institute (CRUK CI) Seminars in Cancer series.

Tell a friend about this talk:

This talk is included in these lists:

Note that ex-directory lists are not shown.


© 2006-2024, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity